This study systematically evaluates the efficacy and safety of albumin-bound paclitaxel and paclitaxel in esophageal cancer treatment using evidence-based medicine, aiming to provide a basis for clinical decision-making. The gene discussed is ALB; the disease is esophageal cancer.